Subjects:
Free Research Articles
Topics:
lenalidomide, multiple myeloma, older adult, triplets

In the article beginning on page 1102 in the 3 March 2016 issue, there are errors in some of the data related to patients’ ages. The median age of patients in the lenalidomide-dexamethasone (Rd) group should be 73 years, not 74 years (fifth sentence of “Results,” pages 1103-1104, and Table 1, page 1105).

In Table 1, the numbers of patients who are ages >75 years should be 80 (37%), not 86 (39%), in the melphalan-prednisone-lenalidomide (MPR) group; 73 (33%), not 80 (36%), in the cyclophosphamide-prednisone-lenalidomide (CPR) group; and 77 (35%), not 83 (37%), in the Rd group. The corrected Table 1 is shown below.

Table 1

Patient demographic and baseline characteristics

CharacteristicMPR (n = 218) No. (%)CPR (n = 222) No. (%)Rd (n = 222) No. (%)
Age, y 63-91 63-87 50-89 
 Median 74 73 73 
 >75 80 (37) 73 (33) 77 (35) 
Male sex 108 (50) 106 (48) 108 (49) 
Karnofsky score 60-100 60-100 60-100 
 Median 80 90 90 
 <80 52 (24) 44 (20) 44 (20) 
Fitness    
 Fit 89 (41) 98 (44) 98 (45) 
 Intermediate fitness 79 (36) 70 (32) 57 (26) 
 Frail 49 (23) 54 (24) 65 (28) 
 Data missing 1 (1) 0 2 (1) 
Creatinine clearance (mL/min) 30-168 30-152 30-150 
 Median 70 67 65 
International Staging System score    
 I 61 (28) 59 (27) 62 (28) 
 II 97 (45) 103 (46) 99 (45) 
 III 59 (27) 60 (27) 60 (27) 
 Missing data 1 (0.5) 0 1 (0.5) 
Cytogenetic abnormalities at FISH    
 Data available 163 (75) 177 (80) 185 (83) 
 Data missing 55 (25) 45 (20) 37 (17) 
 High risk* 38 (17) 48 (22) 47 (25) 
CharacteristicMPR (n = 218) No. (%)CPR (n = 222) No. (%)Rd (n = 222) No. (%)
Age, y 63-91 63-87 50-89 
 Median 74 73 73 
 >75 80 (37) 73 (33) 77 (35) 
Male sex 108 (50) 106 (48) 108 (49) 
Karnofsky score 60-100 60-100 60-100 
 Median 80 90 90 
 <80 52 (24) 44 (20) 44 (20) 
Fitness    
 Fit 89 (41) 98 (44) 98 (45) 
 Intermediate fitness 79 (36) 70 (32) 57 (26) 
 Frail 49 (23) 54 (24) 65 (28) 
 Data missing 1 (1) 0 2 (1) 
Creatinine clearance (mL/min) 30-168 30-152 30-150 
 Median 70 67 65 
International Staging System score    
 I 61 (28) 59 (27) 62 (28) 
 II 97 (45) 103 (46) 99 (45) 
 III 59 (27) 60 (27) 60 (27) 
 Missing data 1 (0.5) 0 1 (0.5) 
Cytogenetic abnormalities at FISH    
 Data available 163 (75) 177 (80) 185 (83) 
 Data missing 55 (25) 45 (20) 37 (17) 
 High risk* 38 (17) 48 (22) 47 (25) 

FISH, fluorescent in situ hybridization.

*

At least one among deletion17p (del17) or translocation (4;14) [t(4;14)] or translocation (14;16) [t(14;16)].

View Large

The authors confirm that these modifications do not affect the results of the analyses. The errors have been corrected in the online version, which now differs from the print version.

View Original Article
© 2018 by The American Society of Hematology
2018
Sign in via your Institution